Dr. Linsen Du
General Manager, ChinaVCLS (Voisin Consulting Life Sciences)
Linsen Du leads VCLS in China, where she established the firm’s practice in 2021. She supports biotech, pharmaceutical and MedTech companies with regulatory strategy, market access and clinical trial development in China and the wider APAC region, drawing on more than 15 years in regulatory science and medical affairs. Before VCLS she was Vice President, Regulatory and Medical Affairs at BravoVax in Wuhan, where she helped direct the development of rotavirus, pneumococcal conjugate and COVID-19 vaccines, and lead scientist at Covance’s central laboratory in Singapore. She has consulted for the Bill & Melinda Gates Foundation’s China Vaccine Program and holds a PhD in Biological Sciences from the National University of Singapore.